Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects (Q44160575)

30 November 2017

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects (English)

1 reference

30 November 2017

1 reference

1 reference

coronary artery disease

1 reference

1

Ernst J Schaefer

1 reference

30 November 2017

Judith R McNamara

2

1 reference

30 November 2017

Timothy Tayler

3

1 reference

30 November 2017

Jennifer A Daly

4

1 reference

30 November 2017

Joi A Gleason

5

1 reference

30 November 2017

Leo J Seman

6

1 reference

30 November 2017

Andrea Ferrari

7

1 reference

30 November 2017

Joel J Rubenstein

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

American Journal of Cardiology

30 November 2017

1 reference

30 November 2017

90

1 reference

30 November 2017

7

1 reference

30 November 2017

689-696

1 reference

Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

Effect of corn and coconut oil-containing diets with and without cholesterol on high density lipoprotein apoprotein A-I metabolism and hepatic apoprotein A-I mRNA levels in cebus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902591-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02591-2

1 reference

30 November 2017

1 reference